Ventriculoperitoneal shunt infections and re-infections in children: a multicentre retrospective study

British Journal of Neurosurgery

Volumn 32, Issue 2, 2018, Pages 196-200

  Yakut, Nurhayat ^a   Soysal, Ahmet ^a   Kepenekli Kadayifci, Eda ^a   Dalgic, Nazan ^b   Yılmaz Ciftdogan, Dilek ^c   Karaaslan, Ayse ^a   Akkoc, Gulsen ^a   Ocal Demir, Sevliya ^a   Cagan, Eren ^d   Celikboya, Ezgi ^b   Kanik, Ali ^c   Dagcinar, Adnan ^a   Yilmaz, Adem ^b   Ozer, Fusun ^c   Camlar, Mahmut ^c   Turel, Ozden ^e   Bakir, Mustafa ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Sisli Etfal Education Hospital   (Turkey)

^c Izmir Tepecik Training and Research Hospital   (Turkey)

^d Bursa Sevket Yilmaz Training and Research Hospital   (Turkey)

^e BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

children; re infection; risk factors; Ventriculoperitoneal shunt infection

Indexed keywords

AMIKACIN; AMPHOTERICIN B; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; FLUCONAZOLE; GENTAMICIN; IMIPENEM; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID CULTURE; CHILD; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMBINATION DRUG THERAPY; CONGENITAL MALFORMATION; DEVICE REMOVAL; DISEASE DURATION; FEVER; HEADACHE; HUMAN; HYDROCEPHALUS; INFECTION RISK; INJURY; KLEBSIELLA PNEUMONIAE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MENINGISM; MONOTHERAPY; NEOPLASM; PEDIATRICS; PLEOCYTOSIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PSEUDOMONAS AERUGINOSA; REINFECTION; RETROSPECTIVE STUDY; SHUNT INFECTION; STAPHYLOCOCCUS AUREUS; VOMITING; ADOLESCENT; ANALYSIS; BACTERIAL INFECTION; CLINICAL TRIAL; FEMALE; INFANT; MALE; MICROBIOLOGY; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; RECURRENT DISEASE; RISK FACTOR; TURKEY (BIRD);

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CEREBROSPINAL FLUID PROTEINS; CHILD; CHILD, PRESCHOOL; DEVICE REMOVAL; FEMALE; HUMANS; HYDROCEPHALUS; INFANT; MALE; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TURKEY; VENTRICULOPERITONEAL SHUNT;

EID: 85046040878     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.1080/02688697.2018.1467373     Document Type: Article

References (35)

1. Hirsch JF., Surgery of hydrocephalus: past, present and future. Acta Neurochir (Wien) 1992;116:155–60.
2. Farahmand D, Hilmarsson H, Högfeldt M, et al. Perioperative risk factors for short term shunt revisions in adult hydrocephalus patients. J Neurol Neurosurg Psychiatry 2009;80:1248–53.
3. Prusseit J, Simon M, von der Brelie C, et al. Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children. Pediatr Neurosurg 2009;45:325–36.
4. Rowin ME, Patel VV, Christenson JC., Pediatric intensive care unit nosocomial infections: epidemiology, sources and solutions. Crit Care Clin 2003;19:473–87.
5. McGirt MJ, Zaas A, Fuchs HE, et al. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 2003;36:858–62.
6. Kestle JRW, Garton HJL, Whitehead WE, et al. Management of shunt infections: a multicenter pilot study. J NeuroSurg 2006;105:177–81.
7. Rehman AU, Rehman TU, Bashir HH, et al. A simple method to reduce infection of ventriculoperitoneal shunts. J Neurosurg Pediatr 2010;5:569–72.
8. Schreffler RT, Schreffler AJ, Wittler RR., Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J 2002;21:632–6.
9. McClinton D, Carraccio C, Englander R., Predictors of ventriculoperitoneal shunt pathology. Pediatr Infect Dis J 2001;20:593–7.
10. Attenello FJ, Garces-Ambrossi GL, Zaidi HA, et al. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters. Neurosurgery 2010;66:284–9.
11. Raffa G, Marseglia L, Gitto E, et al. Antibiotic-impregnated catheters reduce ventriculoperitoneal shunt infection rate in high-risk newborns and infants. Childs Nerv Syst 2015;31:1129–38.
12. Reddy GK, Bollam P, Caldito G., Ventriculoperitoneal shunt surgery and the risk of shunt infection in patients with hydrocephalus: long-term single institution experience. World Neurosurg 2012;78:155–63.
13. Simon TD, Hall M, Riva-Cambrin J, Hydrocephalus Clinical Research Network, et al. Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Neurosurg Pediatr 2009;4:156–65.
14. Adams DJ, Rajnik M., Microbiology and treatment of cerebrospinal fluid shunt infections in children. Curr Infect Dis Rep 2014;16:427.
15. Clemmensen D, Rasmussen MM, Mosdal CA., Retrospective study of infections after primary VP shunt placement in the newborn with myelomeningocele without prophylactic antibiotics. Childs Nerv Syst 2010;26:1517–21.
16. Gathura E, Poenaru D, Bransford R, et al. Outcomes of ventriculoperitoneal shunt insertion in Sub-Saharan Africa. J Neurosurg Pediatr 2010;6:329–35.
17. Lee JK, Seok JY, Lee JH, et al. Incidence and risk factors of ventriculoperitoneal shunt infections in children: a study of 333 consecutive shunts in 6 years. J Korean Med Sci 2012;27:1563–8.
18. Pople IK, Bayston R, Hayward RD., Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 1992;77:29–36.
19. Renier D, Lacombe J, Pierre-Kahn A, et al. Factors causing acute shunt infection. Computer analysis of 1174 operations. J NeuroSurg 1984;61:1072–8.
20. Morina Q, Kelmendi F, Morina A, et al. Ventriculoperitoneal shunt complications in a developing country: a single institution experience. Med Arh 2013;67:36–8.
21. Turgut M, Alabaz D, Erbey F, et al. Cerebrospinal fluid shunt infections in children. Pediatr Neurosurg 2005;41:131–6.
22. Lima MM, Pereira CU, Silva AM., Ventriculoperitoneal shunt infections in children and adolescents with hydrocephalus. Arq NeuroPsiquiatr 2007;65:118–23.
23. Stone JJ, Walker CT, Jacobson M, et al. Revision rate of pediatric ventriculoperitoneal shunts after 15 years. J Neurosurg Pediatr 2013;11:15–9.
24. Moussa WM, Mohamed MA., Efficacy of postoperative antibiotic injection in and around ventriculoperitoneal shunt in reduction of shunt infection: a randomized controlled trial. Clin Neurol Neurosurg 2016;143:144–9.
25. Isla Guerrero A, Peña García P, Ortega V, et al. Antibiotic therapy of infected cerebrospinal fluid in hydrocephalus treated by a shunt. An Esp Pediatr 1988;29:435–9.
26. Parker SL, Attenello FJ, Sciubba DM, et al. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts. Childs Nerv Syst 2009;25:77–83.
27. Langley JM, Gravel D, Moore D, et al. Study of cerebrospinal fluid shunt- associated infections in the first year following placement, by the Canadian nosocomial infection surveillance program. Infect Control Hosp Epidemiol 2009;30:285–8.
28. Montero A, Romero J, Vargas JA, et al. Candida infection of cerebrospinal fluid shunt devices: report of two cases and review of the literature. Acta Neurochir (Wien) 2000;142:67–74.
29. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267–84.
30. Whitehead WE, Kestle JR., The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons. Pediatr Neurosurg 2001;35:205–10.
31. Arnell K, Enblad P, Wester T, et al. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections. J NeuroSurg 2007;107:213–9.
32. Simon TD, Hall M, Dean JM, et al. Reinfection following initial cerebrospinal fluid shunt infection. J Neurosurg Pediatr 2010;6:277–85.
33. Tuan TJ, Thorell EA, Hamblett NM, et al. Treatment and microbiology of repeated cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 2011;30:731–5.
34. Kulkarni AV, Rabin D, Lamberti-Pasculli M, et al. Repeat cerebrospinal fluid shunt infection in children. Pediatr Neurosurg 2001;35:66–71.
35. Gutierrez-Murgas Y, Snowden JN., Ventricular shunt infections: immunopathogenesis and clinical management. J Neuroimmunol 2014;276:1–8.